Check out your Company Bowl for anonymous work chats.
Ancillare is proud to be a sponsor for ELPRO's Virtual 5K for Cancer Research taking place from October 1-31, 2022. You pick any day in October! Participants can WALK or RUN in the Move Mountains charity race to raise funds for The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute to support their innovative cancer research efforts. Register TODAY.
Hear what our Partners are saying...
Ancillare is a Drug Free Workplace Due to requirements of our Sponsors, all job offers are contingent upon the satisfactory completion of the pre-employment 14 panel drug screen (which includes marijuana) and a background check (which includes a criminal record check, driving record and valid ID, educational verification, and professional license verification), if applicable.
Ancillare Launches Employee Training and Development Program, Offers Tuition Assistance Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, is proud to announce the official launch of Ancillare University, a set of professional development courses for its staff. Read more at https://www.einnews.com/pr_news/573790962/ancillare-launches-employee-training-and-development-program-offers-tuition-assistance
Ancillare’s Impact: Our Drive to Reach Further (And Closer) For those of us working every day to support clinical research, we know we are contributing to the greater goal of improving patients’ lives. Many of us entered the industry out of a desire to make a difference for those suffering around the world. COVID-19 vaccines, which offered immediate protection for ourselves and our loved ones, gave us a glimpse at the real world outcomes of our work. But when those outcomes are not visible, we can lose sight of the impact we are making. Sometimes, we are lucky enough to get a reminder of the tangible impact we make right here at home. Ancillare is proud to celebrate one of those stories from our employee, Jessica. Read Jessica's story:
Ancillare Joins Decentralized Trials & Research Alliance (DTRA) Horsham, Pa. — February 8, 2022. Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, announced today it has joined the Decentralized Trials & Research Alliance (DTRA), an historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. “Decentralized trials are the future of clinical research, and a well-managed supply chain is foundational to their success,” said Dr. Joanne Santomauro, Chief Executive Officer, Ancillare. “As a member of the DTRA, Ancillare will help pave the way to broader adoption of decentralized trials through awareness and innovation of the global Clinical Trial Ancillary Supply Chain.”
Ancillare's CEO Joanne Santomauro featured in the latest issue of PharmaVOICE discussing The Cost of Overlooking Ancillary Supplies in Protocol Development. Read more
Read our latest article: Prepared vs. Proactive: Is Your Clinical Trial Ancillary Supply Chain™ Supporting Trial Success?
Ancillare’s Impact: Our Drive to Reach Further (And Closer) For those of us working every day to support clinical research, we know we are contributing to the greater goal of improving patients’ lives. Many of us entered the industry out of a desire to make a difference for those suffering around the world. COVID-19 vaccines, which offered immediate protection for ourselves and our loved ones, gave us a glimpse at the real world outcomes of our work. But when those outcomes are not visible, we can lose sight of the impact we are making. Sometimes, we are lucky enough to get a reminder of the tangible impact we make right here at home. Ancillare is proud to celebrate one of those stories from our employee, Jessica. Read more about Jessica's Story:
Hear from Ancillare's CEO, Joanne Santomauro on addressing the challenges faced during the pandemic while managing COVID-19 clinical trials.
